非精神活性大麻素调节无知觉和炎症,与鼠标模型的脉炎相关
Elana Y Laks1, Hongbo Li2, Sara Jane Ward2
1Department of Prosthodontics, School of Dentistry, Indiana University, Indianapolis, IN 46202, USA.
Biomolecules
|May 27, 2023
概括
非精神活性大麻化合物,特别是β-caryophyllene (β-CP),在治疗牙痛方面表现有前途. 这项研究发现,β-CP在动物模型中有效降低了口腔面部疼痛和炎症.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 牙科研究 牙科研究
背景情况:
- 口腔面部疼痛是紧急牙医诊所的常见原因,需要改进治疗方法.
- 大麻成分正在研究疼痛管理中的治疗潜力.
- 非精神活性化合物提供了传统止痛药的替代品,副作用较少.
研究的目的:
- 为了评估非精神活性大麻成分,大麻二醇 (CBD) 和β-caryophyllene (β-CP) 的疗效,在治疗口腔面部疼痛和炎症.
- 研究CBD和β-CP对动物牙暴露模型中的疼痛敏感性和神经炎症的影响.
主要方法:
- 使用一种动物模型,对下毛脉暴露.
- 在特定的时间点,老鼠接受了载体,CBD (5 mg/kg) 或β-CP (30 mg/kg) 的治疗.
- 测量了面膜机械体,并分析了三关节神经炎症标志物 (AIF,CCL2).
主要成果:
- 纸暴露引起显著的面部敏感性和三角神经炎症.
- β-caryophyllene (β-CP) 显著降低了面部敏感性,并降低了AIF和CCL2的表达.
- 大麻 (CBD) 仅显示出AIF表达的显著减少,而不是面部敏感性.
结论:
- β-caryophyllene在治疗牙脉暴露引起的口腔面部疼痛和相关炎症方面显示出显著的治疗潜力.
- 这些发现提供了临床前证据,支持用于治疗牙痛的非精神活性大麻素基药物疗法.
- 需要进一步研究β-CP作为治疗牙痛的非精神活性剂.
相关概念视频
Nociception
28.1K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.1K
Analgesia and Pain Management
673
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
673


